Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Asimov
AddedFeb 13, 2024
UpdatedJun 18, 2026
Asimov

Asimov

Asimov, a cellular engineering firm, advances biologics and gene therapy design through synthetic biology and AI tools.

HQ
Boston, MA, US
Founded
2017
Overview
Compare
Fundraising
Employees
Website

Asimov, founded in Boston, MA, is a pioneering cellular engineering company focused on advancing the design and manufacture of biologics and gene therapies. The company integrates mammalian synthetic biology, computer-aided design, and machine learning to develop sophisticated tools for programming living cells. Asimov's core mission is to revolutionize healthcare by creating innovative solutions that enhance the precision and efficacy of genetic treatments. Their product offerings include the CHO Edge System, LV Edge System, and AAV Edge System, targeting the biologics and gene therapy markets.

Notable figures affiliated with Asimov include a multi-disciplinary team of experts in synthetic biology and AI. The company has attracted significant interest from investors in the biotech sector, contributing to its rapid growth and development. Key achievements include the successful deployment of their Edge Systems, which have set new standards in genetic design and manufacturing. Asimov's impact is marked by its contributions to advancing therapeutic solutions, potentially transforming the landscape of modern medicine.

Asimov - Similar Companies

AI Proteins logo

AI Proteins

aiproteinstx.com

Absci logo

Absci

absci.com

Think Bioscience logo

Think Bioscience

AsimicA logo

AsimicA

asimica.com

Ginkgo Bioworks logo

Ginkgo Bioworks

ginkgobioworks.com

Synvivia logo

Synvivia

synvivia.com

Generate Biomedicines logo

Generate Biomedicines

64x Bio logo

64x Bio

64xbio.com

20n logo

20n

1910 logo

1910

1910genetics.com

Artisan Bio logo

Artisan Bio

artisancells.com

Cellanome logo

Cellanome

cellanome.com

Insilico Medicine logo

Insilico Medicine

insilico.com

Twist Bioscience logo

Twist Bioscience

Trailhead Biosystems logo

Trailhead Biosystems

Asimov - Quick Facts

Who are Asimov's competitors?

Companies similar to Asimov include AI Proteins, Absci, Think Bioscience and AsimicA.

When was Asimov founded?

Asimov was founded in 2017.

Where is Asimov's headquarters located?

Asimov's headquarters is located in Boston, MA, US.

When was Asimov's last funding round?

Asimov's most recent funding round was for $175M (USD) in January 2023.

How much has Asimov raised to-date?

As of Jan 5, 2023, Asimov has raised a total of $205M (USD).

How many employees does Asimov have?

Asimov has 111 employees as of Feb 4, 2024.

Asimov - Classification

Ownership
  • Venture Capital
Technology
  • AI
  • Machine Learning
Geographic Exposure
  • United States
Model
  • Platform
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Biologics
  • Gene Therapy
Tags
  • Biotech
  • SaaS
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 15 more industry codes
NAICS
  • 513200Software Publishers
  • 541500Computer Systems Design and Related Services
  • 510000Information
  • 620000Health Care and Social Assistance
  • 513000Publishing Industries
  • 513210Software Publishers
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 8000Health Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 8040Offices And Clinics Of Other Health Practitioners
  • 7371Computer Programming Services
  • 7372Prepackaged Software
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified